Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Other(1)

Detailed Status

Completed3

Recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting120%

unknown120%

completed360%

Recent Activity

1 active trials

Showing 5 of 5

recruitingnot_applicable

Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions

NCT05927272

unknownnot_applicable

Atopic Dermatitis: Early Gene Expression Changes as Predictors of Therapeutic Response to Narrow-band UVB Treatment

NCT03402412

completed

Clinical Trials (5)

Showing 5 of 5 trials

NCT05927272Not Applicable

Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions

Recruiting

NCT03402412Not Applicable

Atopic Dermatitis: Early Gene Expression Changes as Predictors of Therapeutic Response to Narrow-band UVB Treatment

Unknown

NCT02330380

Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation

Completed

NCT01512537Not Applicable

Alternative Treatments of Vitamin D Deficiency

Completed

NCT00398723Not Applicable

Narrowband UVB Treatment in Patients With Vitiligo

Completed

All 5 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 5